Although the SHH signaling pathway is most likely activated, a heterozygous loss of P53 additionally to the GLI2 overexpression did not lead to development of MB, but to neurological symptoms such as ataxia, paralysis, and bodyweight loss, also observed for hG::Gli2N+ mice. The gene discussed is GLI2; the disease is cerebellar ataxia.